$OLPX
OLAPLEX HOLDINGS, INC. Stock $olpx

$olpx Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000186872623000037 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$109.2M	$113.8M	$186.2M
YoY Change	-48.2%	-38.89%	57.63%
Cost Of Revenue	$31.75M	$32.98M	$44.99M
YoY Change	-41.72%	-26.7%	83.46%
Gross Profit	$77.50M	$80.81M	$141.2M
YoY Change	-50.46%	-42.77%	50.87%
Gross Profit Margin	70.94%	71.02%	75.84%
Selling, General & Admin	$48.41M	$34.92M	$22.31M
YoY Change	85.41%	56.51%	97.82%
% of Gross Profit	62.47%	43.22%	15.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.32M	$116.0K	$75.00K
YoY Change	-17.75%	54.67%
% of Gross Profit	13.32%	0.14%	0.05%
Operating Expenses	$58.74M	$45.25M	$32.58M
YoY Change	61.34%	38.88%	51.8%
Operating Profit	$18.76M	$35.56M	$108.6M
YoY Change	-84.37%	-67.26%	50.59%
Interest Expense	-$10.21M	$10.54M	$11.46M
YoY Change	17.39%	-8.0%	-26.07%
% of Operating Profit	-54.41%	29.65%	10.55%
Other Income/Expense, Net	-$600.0K	$242.0K	-$19.18M
YoY Change	-50.98%	-101.26%	40708.51%
Pretax Income	$7.953M	$25.26M	$77.99M
YoY Change	-92.78%	-67.61%	37.82%
Income Tax	$1.797M	$4.298M	$16.02M
% Of Pretax Income	22.6%	17.01%	20.55%
Net Earnings	$6.156M	$20.96M	$61.96M
YoY Change	-92.98%	-66.17%	36.09%
Net Earnings / Revenue	5.64%	18.42%	33.28%
Basic Earnings Per Share	$0.01	$0.03	$0.10
Diluted Earnings Per Share	$0.01	$0.03	$0.09
COMMON SHARES
Basic Shares Outstanding	654.3M shares	651.9M shares	648.8M shares
Diluted Shares Outstanding	680.3M shares	683.5M shares	693.0M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$378.4M	$369.3M	$143.3M
YoY Change	91.09%	157.65%
Cash & Equivalents	$378.4M	$369.3M	$143.3M
Short-Term Investments
Other Short-Term Assets	$13.40M	$16.67M	$8.196M
YoY Change	132.4%	103.33%
Inventory	$128.5M	$132.0M	$117.5M
Prepaid Expenses
Receivables	$50.30M	$45.52M	$68.91M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$570.6M	$563.5M	$337.9M
YoY Change	34.12%	66.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$932.0K	$1.026M	$740.0K
YoY Change	39.1%	38.65%
Goodwill	$168.3M	$168.3M	$168.3M
YoY Change		0.0%
Intangibles	$971.7M	$983.0M	$1.031B
YoY Change		-4.68%
Long-Term Investments			$6.364M
YoY Change
Other Assets	$11.35M	$10.00M	$6.364M
YoY Change	-4.44%	57.2%
Total Long-Term Assets	$1.152B	$1.162B	$1.217B
YoY Change	-4.47%	-4.47%
TOTAL ASSETS
Total Short-Term Assets	$570.6M	$563.5M	$337.9M
Total Long-Term Assets	$1.152B	$1.162B	$1.217B
Total Assets	$1.723B	$1.726B	$1.555B
YoY Change	5.59%	11.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.67M	$9.408M	$29.01M
YoY Change	-33.98%	-67.56%
Accrued Expenses	$24.65M	$19.92M	$11.36M
YoY Change	-23.42%	75.33%
Deferred Revenue	$2.077M	$2.230M	$5.004M
YoY Change		-55.44%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.750M	$6.750M	$6.750M
YoY Change	0.0%	0.0%
Total Short-Term Liabilities	$61.25M	$58.23M	$82.17M
YoY Change	-29.58%	-29.14%
LONG-TERM LIABILITIES
Long-Term Debt	$651.7M	$653.0M	$658.3M
YoY Change	-0.81%	-0.81%
Other Long-Term Liabilities	$189.4M	$205.7M	$225.1M
YoY Change	-9.16%	-8.64%
Total Long-Term Liabilities	$841.1M	$653.0M	$658.3M
YoY Change	-2.82%	-0.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$61.25M	$58.23M	$82.17M
Total Long-Term Liabilities	$841.1M	$653.0M	$658.3M
Total Liabilities	$905.1M	$919.2M	$965.6M
YoY Change	-4.98%	-4.8%
SHAREHOLDERS EQUITY
Retained Earnings	$492.0M	$485.8M	$282.7M
YoY Change		71.82%
Common Stock	$654.0K	$653.0K	$648.0K
YoY Change		0.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$817.9M	$806.6M	$589.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.723B	$1.726B	$1.555B
YoY Change	5.59%	11.01%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$6.156M	$20.96M	$61.96M
YoY Change	-92.98%	-66.17%	36.09%
Depreciation, Depletion And Amortization	$10.32M	$116.0K	$75.00K
YoY Change	-17.75%	54.67%
Cash From Operating Activities	$27.00M	$48.09M	$71.97M
YoY Change	-51.86%	-33.18%	74.3%
INVESTING ACTIVITIES
Capital Expenditures	$1.365M	$107.0K	$68.00K
YoY Change	-399.34%	57.35%
Acquisitions
YoY Change
Other Investing Activities	-$1.996M
YoY Change
Cash From Investing Activities	-$1.365M	-$631.0K	-$489.0K
YoY Change	199.34%	29.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-16.56M	-$926.0K	-$114.5M
YoY Change	1648.15%	-99.19%	2505.71%
NET CHANGE
Cash From Operating Activities	27.00M	$48.09M	$71.97M
Cash From Investing Activities	-1.365M	-$631.0K	-$489.0K
Cash From Financing Activities	-16.56M	-$926.0K	-$114.5M
Net Change In Cash	9.078M	$46.53M	-$43.04M
YoY Change	-83.4%	-208.11%	-216.66%
FREE CASH FLOW
Cash From Operating Activities	$27.00M	$48.09M	$71.97M
Capital Expenditures	$1.365M	$107.0K	$68.00K
Free Cash Flow	$25.63M	$47.98M	$71.90M
YoY Change	-54.66%	-33.27%	74.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001868726
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-40860
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Olaplex Holdings, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-1242679
CY2023Q1	dei	City Area Code CityAreaCode	310
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	691-0776
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	OLPX
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	654276766	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	369340000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	322808000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	17499000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	19198000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	45516000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	46220000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	132014000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	144425000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	16665000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8771000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	563535000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	522224000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1026000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1034000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	982962000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	995028000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	168300000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	168300000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10004000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11089000	usd
CY2023Q1	us-gaap	Assets Assets	1725827000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	653000	usd
CY2022Q4	us-gaap	Assets Assets	1697675000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	9408000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9748000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	5799000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3415000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19919000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17107000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	6750000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8438000	usd
CY2023Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	16352000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	16380000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	58228000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	55088000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	653006000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	654333000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2301000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1622000	usd
CY2023Q1	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	205675000	usd
CY2022Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	205675000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	919210000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	916718000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	653776766	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	653776766	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	650091380	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	650091380	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	649000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	318124000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	312875000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2020000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2577000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	485820000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	464856000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	806617000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	780957000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1725827000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1697675000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113787000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	186196000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	31235000	usd
CY2022Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	43222000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1742000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1769000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	32977000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	44991000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	80810000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	141205000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	34924000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22314000	usd
CY2023Q1	olpx	Amortization Of Other Intangible Assets AmortizationOfOtherIntangibleAssets	10323000	usd
CY2022Q1	olpx	Amortization Of Other Intangible Assets AmortizationOfOtherIntangibleAssets	10266000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	45247000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	32580000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	35563000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	108625000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	10543000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	11460000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18803000	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	242000	usd
CY2022Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	377000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	242000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19180000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25262000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	77985000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4298000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16024000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	20964000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	61961000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	651730993	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	648813998	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	683485182	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	693021097	shares
CY2023Q1	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	-557000	usd
CY2022Q1	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-557000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	20407000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	61961000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	780957000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	20964000	usd
CY2023Q1	olpx	Stock Issued During Period Value Non Option Equity Instruments Exercised StockIssuedDuringPeriodValueNonOptionEquityInstrumentsExercised	326000	usd
CY2023Q1	olpx	Share Based Payment Arrangement Shares Withheld For Tax Withholding Obligation Amount ShareBasedPaymentArrangementSharesWithheldForTaxWithholdingObligationAmount	390000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3299000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2018000	usd
CY2023Q1	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	-557000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	806617000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	524298000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	61961000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1632000	usd
CY2022Q1	olpx	Stock Issued During Period Value Non Option Equity Instruments Exercised StockIssuedDuringPeriodValueNonOptionEquityInstrumentsExercised	348000	usd
CY2022Q1	olpx	Share Based Payment Arrangement Shares Withheld For Tax Withholding Obligation Amount ShareBasedPaymentArrangementSharesWithheldForTaxWithholdingObligationAmount	920000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2018000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1696000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1696000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	589015000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	20964000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	61961000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1742000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1769000	usd
CY2023Q1	olpx	Amortization Of Other Intangible Assets AmortizationOfOtherIntangibleAssets	10323000	usd
CY2022Q1	olpx	Amortization Of Other Intangible Assets AmortizationOfOtherIntangibleAssets	10266000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	2610000	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	4324000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	116000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	75000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	453000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	146000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	847000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1712000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	48089000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18803000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-265000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-704000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	28135000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10407000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	22899000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	7108000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1425000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-340000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9838000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5116000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	14412000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	28000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	0	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	71969000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	107000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	68000	usd
CY2023Q1	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	524000	usd
CY2022Q1	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	421000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-631000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-489000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2513000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	64000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	572000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	3375000	usd
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	777005000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	675000000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11944000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-926000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-114521000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	46532000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-43041000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	322808000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186388000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	369340000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	143347000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	91000	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	12000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	13853000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	10597000	usd
CY2023Q1	olpx	Initial Public Offering Costs Incurred But Not Yet Paid InitialPublicOfferingCostsIncurredButNotYetPaid	0	usd
CY2022Q1	olpx	Initial Public Offering Costs Incurred But Not Yet Paid InitialPublicOfferingCostsIncurredButNotYetPaid	145000	usd
CY2023Q1	olpx	Liability Reclassification To Additional Paid In Capital LiabilityReclassificationToAdditionalPaidInCapital	0	usd
CY2022Q1	olpx	Liability Reclassification To Additional Paid In Capital LiabilityReclassificationToAdditionalPaidInCapital	1632000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Examples of estimates and assumptions include: for revenue recognition, determining the nature and timing of satisfaction of performance obligations, variable consideration, and other obligations such as product returns and refunds; loss contingencies; the fair value of share-based options and stock settled stock appreciation rights (“SARs”); the fair value of and/or potential impairment of goodwill and intangible assets for the Company’s reporting unit; the fair value of the Company’s interest rate cap; useful lives of the Company’s tangible and intangible assets; allowance for promotions; estimated income tax and tax receivable payments; the net realizable value of, and demand for the Company’s inventory. Actual results and outcomes may differ from management’s estimates and assumptions due to risks and uncertainties.</span></div>
CY2021Q4	olpx	Tax Receivable Agreement Percent Of Tax Benefits With Provided Payment TaxReceivableAgreementPercentOfTaxBenefitsWithProvidedPayment	0.85
CY2021Q4	olpx	Tax Receivable Agreement Percent Of Tax Benefits Retained By Company TaxReceivableAgreementPercentOfTaxBenefitsRetainedByCompany	0.15
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	222100000	usd
CY2022	olpx	Related Party Transaction Term Of Agreement RelatedPartyTransactionTermOfAgreement	P13Y
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts presented have been reclassified within “Note 6 - Accrued Expenses and Other Current Liabilities” as of </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to conform with the current period presentation, including a prior year reclassification from Other accrued expenses and current liabilities to Accrued advertising. The reclassifications had no effect on the Company’s Total current liabilities.</span></div>
CY2023Q1	olpx	Number Of Business Channels NumberOfBusinessChannels	3	businesschannel
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113787000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	186196000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	113787000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	186196000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	40224000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	36194000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	91790000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	108231000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	132014000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	144425000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1144446000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	161484000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	982962000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	168300000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	168300000	usd
CY2023Q1	olpx	Intangible Assets Gross Including Goodwill IntangibleAssetsGrossIncludingGoodwill	1312746000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	161484000	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1151262000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1143922000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	148894000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	995028000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	168300000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	168300000	usd
CY2022Q4	olpx	Intangible Assets Gross Including Goodwill IntangibleAssetsGrossIncludingGoodwill	1312222000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	148894000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1163328000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3911000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3187000	usd
CY2023Q1	olpx	Accrued Legal Settlement Current AccruedLegalSettlementCurrent	3900000	usd
CY2022Q4	olpx	Accrued Legal Settlement Current AccruedLegalSettlementCurrent	0	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2792000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4092000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2230000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2015000	usd
CY2023Q1	olpx	Accrued Freight Current AccruedFreightCurrent	2213000	usd
CY2022Q4	olpx	Accrued Freight Current AccruedFreightCurrent	3283000	usd
CY2023Q1	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	2092000	usd
CY2022Q4	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	1356000	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	703000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	814000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2078000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2360000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19919000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17107000	usd
CY2023Q1	olpx	Accrued Legal Settlement Current AccruedLegalSettlementCurrent	3900000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8494000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8854000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	659756000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	662771000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	6750000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8438000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	653006000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	654333000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	10543000	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	11460000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	659800000	usd
CY2023Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	593100000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	662800000	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	624600000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	109620	shares
CY2023Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	83501	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3659267	shares
CY2022Q1	olpx	Deferred Compensation Arrangement With Individual Converted In Period Number Of Units DeferredCompensationArrangementWithIndividualConvertedInPeriodNumberOfUnits	886950	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	117180	shares
CY2022Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	55244	shares
CY2023Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	CONTINGENCIESFrom time to time, the Company is subject to various legal actions arising in the ordinary course of business. The Company cannot predict with reasonable assurance the outcome of these legal actions brought against us as they are subject to uncertainties. Accordingly, any settlement or resolution in these legal actions may occur and affect the Company’s net income in such period as the settlement or resolution.<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pending Legal Proceedings: </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 17, 2022, a putative securities class action was filed against the Company and certain of its current and former officers and directors in the United States District Court for the Central District of California, captioned Lilien v. Olaplex Holdings, Inc. et al., No. 2:22-cv-08395. A consolidated complaint was filed on April 28, 2023, which names as additional defendants the underwriters for the Company’s IPO and various stockholders that sold shares of common stock of the Company in the IPO. The action is brought on behalf of a putative class of purchasers of the Company’s common stock in or traceable to the Company’s IPO and asserts claims under Sections 11, 12, and 15 of the Securities Act of 1933. The action seeks certification of the putative class, compensatory damages, attorneys’ fees and costs, and any other relief that the court determines is appropriate. The Company expects the underwriter defendants to notify the Company of their intent to seek indemnification from the Company pursuant to the IPO underwriting agreement regarding the claims asserted in this action. The Company intends to vigorously defend the pending lawsuit.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 9, 2023, twenty-eight plaintiffs filed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Albahae, et al. v. Olaplex Holdings, Inc., et al.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No. 2:23-cv-00982, a complaint alleging personal and economic injury and asserting claims for breach of warranty, negligence/gross negligence, products liability, unjust enrichment, and violations of California False Advertising Law and Unfair Competition Law, against the Company and Cosway Company, Inc., the Company’s primary contract manufacturer, in the United States District Court for the Central District of California. On March 2, 2023, the plaintiffs amended the complaint to include seventy-three additional plaintiffs. The plaintiffs allege that certain ingredients used in some Company products have purportedly caused irritation or posed a hazard to consumers, and that the Company engaged in misrepresentation with respect to those products. The plaintiffs seek actual and consequential damages, punitive damages, restitution in the form of disgorgement of profits, attorneys’ fees and costs, and any other relief that the court determines is appropriate. The Company intends to vigorously defend the pending lawsuit. On April 17, 2023, the Company moved to dismiss the plaintiffs’ claims. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any potential loss associated with these pending legal proceedings is not probable or reasonably estimable at this time.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023 and December 31, 2022, the Company was not subject to any other currently pending legal matters or claims that could have a material adverse effect on its financial position, results of operations, or cash flows should such litigation be resolved unfavorably.</span></div>
CY2023Q1	us-gaap	Loss Contingency Number Of Plaintiffs LossContingencyNumberOfPlaintiffs	28	plaintiff
CY2023Q1	us-gaap	Loss Contingency Number Of Plaintiffs LossContingencyNumberOfPlaintiffs	73	plaintiff
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	20964000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	61961000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	651730993	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	648813998	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	31754189	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	44207099	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	683485182	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	693021097	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001868726-23-000037-index-headers.html	Edgar Link	pending
0001868726-23-000037-index.html	Edgar Link	pending
0001868726-23-000037.txt	Edgar Link	pending
0001868726-23-000037-xbrl.zip	Edgar Link	pending
ex102formofrsuagreement.htm	Edgar Link	pending
ex311-ceocertificationq120.htm	Edgar Link	pending
ex312-cfocertificateq12023.htm	Edgar Link	pending
ex321-ceocertificateq12023.htm	Edgar Link	pending
ex322-cfocertificateq12023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
olpx-20230331.htm	Edgar Link	pending
olpx-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
olpx-20230331_cal.xml	Edgar Link	unprocessable
olpx-20230331_def.xml	Edgar Link	unprocessable
olpx-20230331_lab.xml	Edgar Link	unprocessable
olpx-20230331_pre.xml	Edgar Link	unprocessable
olpx-20230331_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OLPX
OLAPLEX HOLDINGS, INC. Stock $olpx

2023 Q2 Form 10-Q Financial Statement

#000186872623000037 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OLPX OLAPLEX HOLDINGS, INC. Stock $olpx

2023 Q2 Form 10-Q Financial Statement

#000186872623000037 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OLPX
OLAPLEX HOLDINGS, INC. Stock $olpx